Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Current Fungal Infection Reports
Erschienen in: Current Fungal Infection Reports 4/2011

01.12.2011 | Epidemiologic Aspects of Fungal Infections (Tom M. Chiller, Section Editor)

Histoplasmosis: Epidemiology in Latin America

verfasst von: Beatriz L. Gómez

Erschienen in: Current Fungal Infection Reports | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Histoplasmosis is a frequent health problem in Latin American countries, but the fact that it is not a reportable disease prevents reliable estimates of its real incidence and impact on public health. Epidemiologic and clinical data remain patchy in general, and in some countries the information available is very limited. Histoplasmosis has a significant public health impact in susceptible populations such as immunosuppressed individuals, in whom the disease is associated with poor outcomes. Limited availability of diagnostic tools in many regions of Latin America is an additional problem, as many patients are already severely ill by the time of the diagnosis. Efforts are therefore necessary to ensure early diagnosis and appropriate treatment, limit the severity of the disease manifestations, and reduce morbidity and mortality. This paper reviews important aspects of the epidemiology of histoplasmosis, the most clinically significant endemic mycosis in Latin America.
Literatur
1.
• Kauffman CA. Histoplasmosis. In: Kauffman CA, Pappas PG, Sobel JD, Dismukes WE, editors. Essentials of Clinical Mycology. 2nd ed. Springer; 2011. p. 321–335. This excellent and recently updated chapter covers all aspects of histoplasmosis.
2.
• Deepe GS, Jr. Histoplasma capsulatum. In: Mandell GL, Bennett JE, Dollin R, editors. Mandell, Douglas and Bennett’s principles and practice of infectious diseases. 7th ed. Philadelphia: Elsevier Churchill Livingstone; 2010. p 3305–3318. This excellent and recently updated chapter covers all aspects of histoplasmosis.
3.
• Brandt ME, Gómez BL, Warnock D. Histoplasma, Blastomyces, Coccidioides, and other dimorphic fungi causing systemic mycoses. In: Versalovic J, Warnock D, editors. Manually of Clinical Microbiology, 10th edition. Volume 2, Section VI, Chapter 120. ASM Press, Washington DC; 2011. p 1902–1918. This excellent and recently updated chapter covers all aspects of endemic mycoses, including histoplasmosis.
4.
•• Colombo AL, Tobón A, Restrepo A et al. Epidemiology of endemic systemic fungal infections in Latin America. Med Mycol. 2011; May 4 (Epub ahead of print). This article presents an excellent review of all epidemiologic aspects of endemic mycoses in Latin America and covers histoplasmosis and recent literature. It has a map adapted from different publications and studies that gives a very clear picture of the endemic areas of histoplasmosis.
5.
Kauffman CA. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev. 2007;20:115–32.PubMedCrossRef
6.
Tobón AM, Agudelo CA, Rosero DS, et al. Disseminated histoplasmosis: comparative study between patients with aquired immunodeficiency syndrome and no-human immunodeficiency virus infected individuals. Am J Trop Med Hyg. 2005;73:576–82.PubMed
7.
Wheat J. Endemic mycoses in AIDS: a clinical review. Clin Microbiol Rev. 1995;8:146–59.PubMed
8.
Kasuga T, White TJ, Koenig G, et al. Phylogeography of the fungal pathogen Histoplasma capsulatum. Mol Ecol. 2003;12:3383–401.PubMedCrossRef
9.
Muniz MM, Morais E, Silva Tavares P, Meyer W, Nosanchuk JD, Zancopé-Oliveira RM. Comparison of different DNA-based methods for molecular typing of Histoplasma capsulatum. Appl EnvMicrobiol. 2010;76(13):4438–47.
10.
Karimi K, Wheat LJ, Conolly P, Cloud G, Hajjeh R, Wheat E, et al. Differences in histoplasmosis in patients with acquired immunodeficiencysyndrome in the United States and Brazil. J Infect Dis. 2002;186:1655–60.PubMedCrossRef
11.
•• Arango M, Castañeda E, Agudelo CI, et al. Histoplasmosis: Results of the Colombian National Survey, 1992–2008. Biomédica. 2011;31(3)3. This study presents the biggest survey conducted in Latin America of cases of histoplasmosis (n = 434) and presents demographic data, risk factors, clinical manifestations, diagnostic methods, and treatment. Interesting comparisons of the various results were done.
12.
Tobón AM, Medina A, Orozco L, et al. Progressive disseminated histoplasmosis in a cohort of patients with HIV coinfection. Acta Médica Colombiana (In Spanish). 2011;36(2):63–7.
13.
Rios Fabra A, Restrepo A, Isturiz R. Fungal infection in Latin American countries. Infect Dis Clin N Am. 1994;8:129–54.
14.
Cuellar Rodriguez J, Avery RK, Budey M, et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis. 2009;49:710–6.PubMedCrossRef
15.
Laniado-Laborin R. Coccidioidomycosis and other endemic mycoses in Mexico. Rev Iberoam Micol. 2007;24:249–58.PubMedCrossRef
16.
Wheat J. Histoplasmosis and coccidioidomycosis in individuals with AIDS. A clinical review. Infect Dis Clin North Am. 1994;8:467–82.PubMed
17.
Baddley JW, Sankara IR, Rodriguez JM, et al. Histoplasmosis in HIV–infected patients in a southern regional medical center: Poor prognosis in the era of highly active antiretroviral therapy. Diagn Microbiol Infect Dis. 2008;62:151–6.PubMedCrossRef
18.
Couppie P, Aznar C, Carme B, Nacher M. American histoplasmosis in developing countries with a special focus on patients with HIV: diagnosis, treatment, and prognosis. Curr Opin Infect Dis. 2006;19:443–9.PubMedCrossRef
19.
de Francesco Daher E, de Sousa Barros FA, da Silva Júnior GB, et al. Risk factors for death in acquired immunodeficiency syndrome–associated disseminated histoplasmosis. Am J Trop Med Hyg. 2006;74:600–3.PubMed
20.
Scheel CM, Samayoa B, Herrera A, et al. Development and evaluation of an enzyme-linked immunosorbent assay to detect Histoplasma capsulatum antigenuria in immunocompromised patients. Clin Vaccine Immunol. 2009;16:852–8.PubMedCrossRef
21.
Mora DJ, dos Santos CTB, Silva-Vergara ML. Disseminated histoplasmosis in acquired immunodeficiency syndrome patients in Uberaba, MG, Brazil. Mycoses. 2008;51:136–40.PubMedCrossRef
22.
Nacher M, Adenis A, Adriouch L, et al. Short report: what is AIDS in the Amazonian and the Guianas? Establishing the burden of disseminated histoplasmosis. Am J Trop Med Hyg. 2011;84(2):239–40.PubMedCrossRef
23.
Gutierrez ME, Canton A, Sosa N, et al. Disseminated histoplasmosis in patients with AIDS in Panama: a review of 104 cases. Clin Infect Dis. 2005;40:1199–202.PubMedCrossRef
24.
Sarosi GA, Voth DW, Dahl BA, Doto IL, Tosh FE. Disseminated histoplasmosis: results of long-term follow up. A center for disease Control cooperative mycoses study. Ann Intern Med. 1971;75:511–6.PubMed
25.
Cermeno V, Cermeno JR, Cova V, Perez GM. Adrenocortical function in patients with systemic mycoses [in Spanish]. Invest Clin. 2007;48:341–8.PubMed
26.
Baraia-Etxaburu AJ, Astigarraga AB, Elorza OR, et al. Primary adrenal failure and AIDS: report of 11 cases and review of the literature [in Spanish]. Rev Clin Esp. 1998;198:74–9.
27.
Daher EF, Silva Jr GB, Barros FAS, et al. Clinical and laboratory features of disseminated histoplasmosis in HIV patients from Brazil. Trop Med Int Health. 2007;12:1108–15.PubMedCrossRef
28.
Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45:807–25.PubMedCrossRef
29.
Centers for Disease Control and Prevention. Histoplasmosis: protecting workers at risk. Washington, DC: Department of Health and Human Services, National Institute for Occupational Safety and Health; 1997 Sep. Report No.: DHHS (NIOSH) Publication No. 97–146.
30.
Carmona-Fonseca J. Análisis estadístico y ecológico-epidemiológico de la sensibilidad a la histoplasmina en Colombia 1950–1968. Antioquia Médica (In Spanish). 1971;21(1):109–54.
31.
Tobon AM, Franco L, Espinal D, et al. Disseminated histoplasmosis in children: the role of itraconazole therapy. Pediatr Infect Dis J. 1996;15:1002–8.PubMedCrossRef
32.
Ordoñez N, Tobón A, Arango M, et al. Brotes de histoplasmosis registrados en el area andina Colombiana. Biomedica. 1997;17:105–11.
33.
Cermeno JR, Hernandez I, Cermeno JJ, et al. Epidemiological survey of histoplasmine and paracoccidioidine skin reactivity in an agricultural area in Bolivar state, Venezuela. Eur J Epidemiol. 2004;19:189–93.PubMedCrossRef
34.
Cermeno JR, Cermeno JJ, Hernandez I, et al. Histoplasmine and paracoccidiodine epidemiological study in Upata, Bolivar state, Venezuela. Trop Med Int Health. 2005;10:216–9.PubMedCrossRef
35.
Murillo J, Castro KG. HIV infection and AIDS in Latin America. Epidemiologic features and clinical manifestations. Infect Dis Clin North Am. 1994;8:1–11.PubMed
36.
Mata-Essayag S, Colella MT, Rosello A, et al. Histoplasmosis: a study of 158 cases in Venezuela, 2000–2005. Medicine (Baltimore). 2008;87:193–202.CrossRef
37.
Hani M, Adenis A, Couppie P, et al. HIV-associated histoplasmosis in French Guiana: recent infection or reactivation? AIDS. 2010;24:1777–8.CrossRef
38.
Oliveira FDM, Unis G, Severo LC. An outbreak of histoplasmosis in the city of Blumenau, Santa Catarina. J Bras Pneumol. 2006;32:375–8.CrossRef
39.
SdC F, Netto CF. Epidemiologic surveys of histoplasmin and paracoccidioidin sensitivity in Brazil. Rev Inst Med Trop Sao Paulo. 1998;40:155–64.CrossRef
40.
Prado M, Barbosa da Silva M, Laurenti R, et al. Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006. Mem Inst Oswaldo Cruz, Rio de Janeiro. 2009;104(3):513–21.CrossRef
41.
Goldani LZ, Aquino VR, Lunardi LW, et al. Two specific strains of Histoplasma capsulatum causing mucocutaneous manifestations of histoplasmosis: preliminary analysis of a frequent manifestation of histoplasmosis in southern Brazil. Mycopathologia. 2009;167:181–6.PubMedCrossRef
42.
Unis G, Oliveira FDM, Severo LC. Disseminated histoplasmosis in Rio Grande do Sul [in Portuguese]. Rev Soc Bras Med Trop. 2004;37:463–8.PubMed
43.
van Gelderen de Komaid A, Duran EL. Histoplasmosis in northwestern Argentina. II: Prevalence of Histoplasmosis capsulati and paracoccidioidomycosis in the population south of Chuscha, Gonzalo and Potrero in the province of Tucuman. Mycopathologia. 1995;129:17–23.PubMedCrossRef
44.
van Gelderen de Komaid A, Duran EL, Madero AM, Carizo V. Histoplasmosis in northwestern Argentina. Epidemiological survey of Chuscha and La Higuera in the province of Tucuman. Eur J Epidemiol. 1992;8:206–10.PubMedCrossRef
45.
van Gelderen de Komaid A, Duran E, Borges de Kestelman I. Histoplasmosis and paracoccidioidomycosis in northwestern Argentina III.Epidemiological survey in Vipos, La Toma, and Choromoro - Trancas, Tucuman, Argentina. Eur J Epidemiol. 1999;15:383–8.PubMed
46.
Negroni R, Duré R, Ortiz Nareto et al. Brote de histoplasmosis en la escuela de cadetes de la base aérea de Morón, Provincia de Buenos Aires, República Argentina. Revista Argentina de Microbiologia (in Spanish). 2010;42:254–260.
47.
Muñoz B, Martínez MA, Palma G, et al. Molecular characterization of Histoplasma capsulatum isolated from an outbreak in treasure hunters. BMC Infect Dis. 2010;8(10):264.CrossRef
48.
Segura L, Rojas M, Pelaez N, et al. Disseminated histoplasmosis and human immunodefi ciency virus type 1 infection: risk factors in Guatemala. Clin Infect Dis. 1997;25:343–4.PubMedCrossRef
49.
Wolff M. Outbreak of acute histoplasmosis in Chilean travelers to the Ecuadorian jungle: an example of geographic medicine [in Spanish]. Rev Med Chil. 1999;127:1359–64.PubMed
50.
Lyon GM, Bravo AV, Espino A, et al. Histoplasmosis associated with exploring a bat-inhabited cave in Costa Rica, 1998–1999. Am J Trop Med Hyg. 2004;70:438–42.PubMed
51.
Weinberg M, Weeks J, Lance-Parker S, et al. Severe histoplasmosis in travelers to Nicaragua. Emerg Infect Dis. 2003;9:1322–5.PubMed
52.
Odio CM, Navarrete M, Carrillo JM, et al. Disseminated histoplasmosis in infants. Pediatr Infect Dis. 1999;18:1065–8.CrossRef
53.
Eza D, Cerrillo G, Moore DAJ, et al. Postmortem findings and opportunistic infections in HIV-positive patients from a public hospital in Peru. Pathol Res Pract. 2006;202:767–75.PubMedCrossRef
Metadaten
Titel
Histoplasmosis: Epidemiology in Latin America
verfasst von
Beatriz L. Gómez
Publikationsdatum
01.12.2011
Verlag
Current Science Inc.
Erschienen in
Current Fungal Infection Reports / Ausgabe 4/2011
Print ISSN: 1936-3761
Elektronische ISSN: 1936-377X
DOI
https://doi.org/10.1007/s12281-011-0073-7

Weitere Artikel der Ausgabe 4/2011

Current Fungal Infection Reports 4/2011 Zur Ausgabe

Epidemiologic Aspects of Fungal Infections (Tom M. Chiller, Section Editor)

Preventing Death from HIV-Associated Cryptococcal Meningitis: The Way Forward

Genomics and Pathogenesis (Shmuel Shoham, Section Editor)

Fungal Infections in Phagocytic Defects

Genomics and Pathogenesis (Shmuel Shoham, Section Editor)

Lessons from Cryptococcal Laccase: From Environmental Saprophyte to Pathogen

Genomics and Pathogenesis (Shmuel Shoham, Section Editor)

Cryptococcus-Related Immune Reconstitution Inflammatory Syndrome (IRIS): Pathogenesis and its Clinical Implications

Genomics and Pathogenesis (Shmuel Shoham, Section Editor)

The Role of Genetics in Host Responses to Mucosal and Invasive Candidiasis

UPDATE

Cutaneous Mucormycosis in Tornado Survivors

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise